HomeIBO • CVE
add
Universal Ibogaine Inc
Previous close
$0.020
Day range
$0.010 - $0.015
Year range
$0.0050 - $0.030
Market cap
2.90M CAD
Avg Volume
51.04K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Revenue | 589.47K | 1,328.42% |
Operating expense | 361.64K | -45.29% |
Net income | -222.20K | 71.97% |
Net profit margin | -37.69 | 98.04% |
Earnings per share | — | — |
EBITDA | -104.64K | 85.79% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 364.59K | 89.89% |
Total assets | 5.61M | -6.58% |
Total liabilities | 3.85M | 14.50% |
Total equity | 1.75M | — |
Shares outstanding | 233.51M | — |
Price to book | 2.00 | — |
Return on assets | -8.38% | — |
Return on capital | -10.33% | — |
Cash Flow
Net change in cash
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Net income | -222.20K | 71.97% |
Cash from operations | -68.03K | 85.84% |
Cash from investing | -9.17K | 95.65% |
Cash from financing | 281.70K | 56.75% |
Net change in cash | 204.50K | 139.97% |
Free cash flow | -3.31K | 99.50% |
About
Founded
2017
Headquarters
Website